• 3 years ago
  • 395 Views

A third Covid-19 vaccine for the U.S.
U.S. federal drug regulators on Saturday authorized Johnson & Johnson’s one-shot vaccine for emergency use, beginning the rollout of millions of doses of a third vaccine that could reach Americans this week.
The announcement came at a critical moment: A decline in coronavirus cases seems to have plateaued in the U.S., which has by far the world’s biggest outbreak.
One shot: Johnson & Johnson’s vaccine requires only one dose, instead of two, to be fully effective. Unlike the other vaccines by Pfizer-BioNTech and Moderna, it can be stored at standard refrigeration temperatures for at least three months.
More than enough: Johnson & Johnson has pledged to provide 100 million doses to the U.S. by the end of June. When combined with the 600 million doses from the other two vaccine suppliers scheduled to arrive by the end of July, there will be more than enough shots to cover any American adult who wants one.
Here are the latest updates and maps of the pandemic.
In other developments:

■ Australia, normally a secondary market for big-brand stage shows developed in New York and London, has become an unexpected pandemic pioneer: a model and a test case for the global theater industry.

■ The Israeli government approved a measure to vaccinate tens of thousands of Palestinians, after facing fierce criticism over the small number of inoculations it had provided to Palestinians living under its occupation.

■ Auckland, New Zealand’s largest city, began a seven-day lockdown on Sunday, with most businesses forced to close, after an outbreak last month linked to a worker at the airport.
The New York Times

Comments are closed.

Simply Confess